Galenica (LTS:0ROG) Risk Assessment

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0ROG Galenica Ltd LTS:0ROG
68 GF Score
Price CHF89.18
GF Value CHF86.36
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Galenica Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Galenica is: Moderate Risk: Sensitive, better choose undervalued stock.

Galenica  (LTS:0ROG) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Galenica Risk Assessment Related Terms

LTS:0ROG vs MCK, CAH, COR: Risk Assessment Comparison

For the Medical Distribution subindustry, Galenica's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galenica Risk Assessment vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Galenica's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Galenica's Risk Assessment falls into.


LTS:0ROG
68GF Score
Galenica Ltd LTS:0ROG
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Galenica (LTS:0ROG) Overvalued in 2026?

Based on GuruFocus' analysis, Galenica stock appears to be overvalued. The current stock price of CHF89.18 is trading 3.3% above its estimated GF Value™ of CHF86.36. GuruFocus considers Galenica to be Fairly Valued.

Key valuation signals for LTS:0ROG:

  • Risk Assessment:
  • GF Value™: CHF86.36 vs. price of CHF89.18 (3.3% above fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the LTS:0ROG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Galenica Business Description

Address Untermattweg 8, Bern, CHE, CH-3027
Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners, and suppliers. Geographically, it operates in Switzerland and Other Countries.
68GF Score

Get the complete analysis for LTS:0ROG

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF89.18
Price
CHF86.36
GF Value